Collaborative Practice in Prostate Cancer: How is this actually done?
DÉTAILS DE L’ACTIVITÉ
CRÉDITS
CUA, IC-OS, and EAU are pleased to bring you a new webinar series: Prostate Cancer and Cardiovascular Disease
Session 3: Collaborative Practice in Prostate Cancer: How is this actually done?
Topics to cover in this session:
- CV decision-making in advanced PC
- Discuss factors that influence recommendations for CABG, valve surgery, transcatheter valve intervention in patients with metastatic PC
- Optimal cardioprotective therapy for high-risk patients
- Should ADT or androgen receptor blockers be withheld (if ever)?
- Acute MI, HTN out of control, etc.
- Any CV conditions that preclude this treatment
- Considerations of complex decisions around antithrombotic therapies
MODERATORS:
Daniel Lenihan
Founder and Past President International Cardio-Oncology Society
Andrew Armstrong
Professor of Medicine. Professor in Surgery.
Professor in Pharmacology and Cancer Biology
Member of the Duke Cancer Institute
Michiel Sedelaar
Professor, Department of Urology
University of Leiden, The Netherlands
SPEAKERS:
Ariane Macedo
Chair of the Cardio-oncology Clinic at Santa Casa de São Paulo
Researcher at Brazilian Clinical Research Institute
Christopher Koo
Genitourinary Medical Oncologist
Consultant, Department of Cardiology
National University Heart Centre, Singapore
Jeffery de Jesus
Consultant/Attending Physician
St. Luke's Medical Center, Philippines